Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Same-Day Discharge Possible After Many Percutaneous CV Procedures: Review

News Daily News

Same-Day Discharge Possible After Many Percutaneous CV Procedures: Review

July 11, 2023

As TAVI Turns 20, How Has the Heart Team Evolved?

News Features

As TAVI Turns 20, How Has the Heart Team Evolved?

Yael L. Maxwell

May 04, 2022

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

Roughly 80% of ESC Guideline Writers Have Financial COIs

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

CMS Extends MitraClip Coverage to Functional MR, Carves Out Imager Role

News Daily News

CMS Extends MitraClip Coverage to Functional MR, Carves Out Imager Role

January 20, 2021

March 2020 News Roundup

News Opinion CV Team Dispatch

March 2020 News Roundup

March 12, 2020

Study Challenges Link Between PCI Volumes and TAVR, TMVr Outcomes

News Daily News

Study Challenges Link Between PCI Volumes and TAVR, TMVr Outcomes

February 18, 2020

News Daily News

Societies Propose Volume, Proficiency Needs for Mitral Interventions

December 17, 2019

Late Follow-up of Surgical MV Repair: Insights for Timing, Innovation

News Daily News

Late Follow-up of Surgical MV Repair: Insights for Timing, Innovation

August 20, 2019

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

TAVR Operators: Can One Do It All or Are Two Still Justified?

News Conference News SCAI 2019

TAVR Operators: Can One Do It All or Are Two Still Justified?

Yael L. Maxwell

June 04, 2019

TAVR More Prevalent in Highly Competitive Hospital Markets

News Conference News STS 2019

TAVR More Prevalent in Highly Competitive Hospital Markets

Yael L. Maxwell

February 04, 2019

News Conference News TVT 2017

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Michael O'Riordan

June 16, 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.